β-carotene genetically-enriched lyophilized orange juice increases antioxidant capacity and reduces β-amyloid proteotoxicity and fat accumulation in Caenorhabditis elegans
• β-carotene content of genetically modified orange was 33-fold higher. • β-carotene-enriched LOJ provided greater antioxidant capacity and stress resistance. • β-carotene-enriched LOJ reduced β-amyloid proteotoxicity. • β-carotene-enriched LOJ showed higher hypolipidemic activity in glucose rich di...
Gespeichert in:
Veröffentlicht in: | Food chemistry. Molecular sciences 2022-12, Vol.5, p.100141-100141, Article 100141 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •
β-carotene content of genetically modified orange was 33-fold higher.
•
β-carotene-enriched LOJ provided greater antioxidant capacity and stress resistance.
•
β-carotene-enriched LOJ reduced β-amyloid proteotoxicity.
•
β-carotene-enriched LOJ showed higher hypolipidemic activity in glucose rich diet.
Citrus sinensis
orange juice is an excellent dietary source of β-carotene, a well-known antioxidant. However, β-carotene concentrations are relatively low in most cultivars. We developed a new orange through metabolic engineering strategy (GS) with 33.72-fold increase in β-carotene content compared to its conventional counterpart (CV). Using
Caenorhabditis elegans
, we found that animals treated with GS showed a greater reduction in intracellular reactive oxygen species (ROS) which is associated with a greater resistance to oxidative stress and induction of the expression of antioxidant genes. Moreover, animals treated with GS orange showed a more effective protection against β-amyloid proteotoxicity and greater hypolipidemic effect under high glucose diet compared to animals treated with CV. These data demonstrate that the increased amount of β-carotene in orange actually provides a greater beneficial effect in
C. elegans
and a valuable proof of principle to support further studies in mammals and humans. |
---|---|
ISSN: | 2666-5662 2666-5662 |
DOI: | 10.1016/j.fochms.2022.100141 |